Aurobindo Pharma informs about press release

29 Nov 2023 Evaluate
Aurobindo Pharma has informed that it enclosed a copy of the Press Release that is being issued by the Company in connection with USFDA approval received by the Company, for Darunavir Tablets, 600 mg and 800 mg.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1134.25 3.10 (0.27%)
29-Apr-2024 09:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1522.70
Dr. Reddys Lab 6266.50
Cipla 1407.15
Zydus Lifesciences 955.10
Lupin 1627.15
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.